Burris, J. L., Ostroff, J. S., Reilly, E. M., Warren, G. W., Shelton, R. C., Mullett, T. W., Adsit, R., Allison, L., Boffa, D., Burris, J., Carter, A., Darville, A., Fiore, M., Hahn, E., Harris, J., Kirstein, L., McCarthy, D., Mullett, T., … Warren, G. (2025). Longitudinal Results From the Nationwide Just ASK Initiative to Promote Routine Smoking Assessment in American College of Surgeons–Accredited Cancer Programs. Journal of Clinical Oncology, 43(7), 821–828. https://doi.org/10.1200/jco.24.00304

Wilky, B. A., Schwartz, G. K., Gordon, M. S., El-Khoueiry, A. B., Bullock, A. J., Henick, B., Agulnik, M., Singh, A., Mahadevan, D., Stebbing, J., Delepine, C., Chand, D., Avagyan, M., Wu, W., Johnson, B., Grossman, J. E., O’Day, S., Trent, J. C., Jones, R. L., & Tsimberidou, A. M. (2025). Botensilimab (Fc-enhanced anti–cytotoxic lymphocyte-association protein-4 antibody) Plus Balstilimab (anti–PD-1 antibody) in Patients With Relapsed/Refractory Metastatic Sarcomas. Journal of Clinical Oncology. https://doi.org/10.1200/jco-24-02524

Holtan, S. G., Bolaños-Meade, J., Al Malki, M. M., Wu, J., Kitko, C. L., Reshef, R., Rezvani, A. R., Shaffer, B. C., Solh, M. M., Yao, J. M., Runaas, L., Elmariah, H., Larkin, K. T., El Jurdi, N., Gooptu, M., Loren, A. W., Hall, A. C., Alousi, A. M., Jamy, O., … Martens, M. J. (2025). Improved Patient-Reported Outcomes With Post-Transplant Cyclophosphamide: A Quality-of-Life Evaluation and 2-Year Outcomes of BMT CTN 1703. Journal of Clinical Oncology. https://doi.org/10.1200/jco.24.00921

Foss, F. M., Kim, Y. H., Prince, H. M., Akilov, O. E., Querfeld, C., Seminario-Vidal, L., Fisher, D. C., Kuzel, T. M., Yannakou, C. K., Geskin, L. J., Feldman, T., Sokol, L., Allen, P. B., Dang, N. H., Cabanillas, F., Wong, H. K., Ooi, C. E., Xing, D., Sauter, N., … Duvic, M. (2024). Efficacy and Safety of Denileukin Diftitox-Cxdl, an Improved Purity Formulation of Denileukin Diftitox, in Patients With Relapsed or Refractory Cutaneous T-Cell Lymphoma. Journal of Clinical Oncology. https://doi.org/10.1200/jco-24-01549

Moertel, C. L., Hirbe, A. C., Shuhaiber, H. H., Bielamowicz, K., Sidhu, A., Viskochil, D., Weber, M. D., Lokku, A., Smith, L. M., Foreman, N. K., Hajjar, F. M., McNall-Knapp, R. Y., Weintraub, L., Antony, R., Franson, A. T., Meade, J., Schiff, D., Walbert, T., Ambady, P., … Sadighi, Z. (2024). ReNeu: A Pivotal, Phase IIb Trial of Mirdametinib in Adults and Children With Symptomatic Neurofibromatosis Type 1-Associated Plexiform Neurofibroma. Journal of Clinical Oncology. https://doi.org/10.1200/jco.24.01034

Le, X., Patel, J. D., Shum, E., Baik, C., Sanborn, R. E., Shu, C. A., Kim, C., Fidler, M. J., Hall, R., Elamin, Y. Y., Tu, J., Blumenschein, G., Zhang, J., Gibbons, D., Gay, C., Mohindra, N. A., Chae, Y., Boumber, Y., Sabari, J., … Heymach, J. V. (2024). A Multicenter Open-Label Randomized Phase II Study of Osimertinib With and Without Ramucirumab in Tyrosine Kinase Inhibitor–Naïve EGFR-Mutant Metastatic Non–Small Cell Lung Cancer (RAMOSE trial). Journal of Clinical Oncology. https://doi.org/10.1200/jco.24.00533

Phillips, K.-A., Kotsopoulos, J., Domchek, S. M., Terry, M. B., Chamberlain, J. A., Bassett, J. K., Aeilts, A. M., Andrulis, I. L., Buys, S. S., Cui, W., Daly, M. B., Eisen, A. F., Foulkes, W. D., Friedlander, M. L., Gronwald, J., Hopper, J. L., John, E. M., Karlan, B. Y., Kim, R. H., … Zaheed, M. (2024). Hormonal Contraception and Breast Cancer Risk for Carriers of Germline Mutations in BRCA1 and BRCA2. Journal of Clinical Oncology. https://doi.org/10.1200/jco.24.00176

Scott, A. J., Kennedy, E. B., Berlin, J., Brown, G., Chalabi, M., Cho, M. T., Cusnir, M., Dorth, J., George, M., Kachnic, L. A., Kennecke, H. F., Loree, J. M., Morris, V. K., Perez, R. O., Smith, J. J., Strickland, M. R., & Gholami, S. (2024). Management of Locally Advanced Rectal Cancer: ASCO Guideline. Journal of Clinical Oncology, 42(28), 3355–3375. https://doi.org/10.1200/jco.24.01160

Jhaveri, K. L., Accordino, M. K., Bedard, P. L., Cervantes, A., Gambardella, V., Hamilton, E., Italiano, A., Kalinsky, K., Krop, I. E., Oliveira, M., Schmid, P., Saura, C., Turner, N. C., Varga, A., Cheeti, S., Hilz, S., Hutchinson, K. E., Jin, Y., Royer-Joo, S., … Juric, D. (2024). Phase I/Ib Trial of Inavolisib Plus Palbociclib and Endocrine Therapy for PIK3CA-Mutated, Hormone Receptor–Positive, Human Epidermal Growth Factor Receptor 2–Negative Advanced or Metastatic Breast Cancer. Journal of Clinical Oncology, 42(33), 3947–3956. https://doi.org/10.1200/jco.24.00110

Apolo, A. B., Girardi, D. M., Niglio, S. A., Nadal, R., Kydd, A. R., Simon, N., Ley, L., Cordes, L. M., Chandran, E., Steinberg, S. M., Lee, S., Lee, M.-J., Rastogi, S., Sato, N., Cao, L., Banday, A. R., Boudjadi, S., Merino, M. J., Toubaji, A., … Mortazavi, A. (2024). Final Results From a Phase I Trial and Expansion Cohorts of Cabozantinib and Nivolumab Alone or With Ipilimumab for Advanced/Metastatic Genitourinary Tumors. Journal of Clinical Oncology, 42(25), 3033–3046. https://doi.org/10.1200/jco.23.02233

Yu, J. B., DeStephano, D. M., Horowitz, D. P., Gross, C. P., & Cheng, S. K. (2024). Reply to O. Saifi et al. Journal of Clinical Oncology. https://doi.org/10.1200/jco-24-01228

Matava, C. T., Peyton, J., von Ungern-Sternberg, B. S., & Ing, C. (2024). Propofol, Anesthesia, and Neurocognitive Outcomes in Patients With Pediatric Leukemia: Are We Missing the Forest for the Trees? Journal of Clinical Oncology, 42(29), 3506–3507. https://doi.org/10.1200/jco.24.00856

Pike, L. R. G., Miao, E., Boe, L. A., Patil, T., Imber, B. S., Myall, N. J., Pollom, E. L., Hui, C., Qu, V., Langston, J., Chiang, V., Grant, M., Goldberg, S. B., Palmer, J. D., Prasad, R. N., Wang, T. J. C., Lee, A., Shu, C. A., Chen, L. N., … Rusthoven, C. G. (2024). Tyrosine Kinase Inhibitors With and Without Up-Front Stereotactic Radiosurgery for Brain Metastases From EGFR and ALK Oncogene–Driven Non–Small Cell Lung Cancer (TURBO-NSCLC). Journal of Clinical Oncology. https://doi.org/10.1200/jco.23.02668

Bumma, N., Richter, J., Jagannath, S., Lee, H. C., Hoffman, J. E., Suvannasankha, A., Zonder, J. A., Shah, M. R., Lentzsch, S., Baz, R., Maly, J. J., Namburi, S., Pianko, M. J., Ye, J. C., Wu, K. L., Silbermann, R., Min, C.-K., Vekemans, M.-C., Munder, M., … Dhodapkar, M. V. (2024). Linvoseltamab for Treatment of Relapsed/Refractory Multiple Myeloma. Journal of Clinical Oncology, 42(22), 2702–2712. https://doi.org/10.1200/jco.24.01008

Van Tine, B. A., Ingham, M. A., Attia, S., Meyer, C. F., Baird, J. D., Brooks-Asplund, E., D’Silva, D., Kong, R., Mwatha, A., O’Keefe, K., Weetall, M., Spiegel, R., & Schwartz, G. K. (2024). Phase Ib Study of Unesbulin (PTC596) Plus Dacarbazine for the Treatment of Locally Recurrent, Unresectable or Metastatic, Relapsed or Refractory Leiomyosarcoma. Journal of Clinical Oncology, 42(20), 2404–2414. https://doi.org/10.1200/jco.23.01684

Xiao, H., Vaidya, R., Hershman, D. L., & Unger, J. M. (2024). Impact of Broadening Trial Eligibility Criteria on the Inclusion of Patients With Brain Metastases in Cancer Clinical Trials: Time Series Analyses for 2012-2022. Journal of Clinical Oncology, 42(16), 1953–1960. https://doi.org/10.1200/jco.23.01777

Yu, J. B., DeStephano, D. M., Jeffers, B., Horowitz, D. P., Soulos, P. R., Gross, C. P., & Cheng, S. K. (2024). Updated Analysis of Comparative Toxicity of Proton and Photon Radiation for Prostate Cancer. Journal of Clinical Oncology, 42(16), 1943–1952. https://doi.org/10.1200/jco.23.01604

Brivio, E., Pennesi, E., Willemse, M. E., Huitema, A. D. R., Jiang, Y., van Tinteren, H. D. R., van der Velden, V. H. J., Beverloo, B. H., den Boer, M. L., Rammeloo, L. A. J., Hudson, C., Heerema, N., Kowalski, K., Zhao, H., Kuttschreuter, L., Bautista Sirvent, F. J., Bukowinski, A., Rizzari, C., Pollard, J., … Zwaan, C. M. (2024). Bosutinib in Resistant and Intolerant Pediatric Patients With Chronic Phase Chronic Myeloid Leukemia: Results From the Phase I Part of Study ITCC054/COG AAML1921. Journal of Clinical Oncology, 42(7), 821–831. https://doi.org/10.1200/jco.23.00897

Arrillaga-Romany, I., Gardner, S. L., Odia, Y., Aguilera, D., Allen, J. E., Batchelor, T., Butowski, N., Chen, C., Cloughesy, T., Cluster, A., de Groot, J., Dixit, K. S., Graber, J. J., Haggiagi, A. M., Harrison, R. A., Kheradpour, A., Kilburn, L. B., Kurz, S. C., Lu, G., … Wen, P. Y. (2024). ONC201 (Dordaviprone) in Recurrent H3 K27M–Mutant Diffuse Midline Glioma. Journal of Clinical Oncology, 42(13), 1542–1552. https://doi.org/10.1200/jco.23.01134

Rahman, R., Trippa, L., Lee, E. Q., Arrillaga-Romany, I., Fell, G., Touat, M., McCluskey, C., Wiley, J., Gaffey, S., Drappatz, J., Welch, M. R., Galanis, E., Ahluwalia, M. S., Colman, H., Nabors, L. B., Hepel, J., Elinzano, H., Schiff, D., Chukwueke, U. N., … Wen, P. Y. (2023). Inaugural Results of the Individualized Screening Trial of Innovative Glioblastoma Therapy: A Phase II Platform Trial for Newly Diagnosed Glioblastoma Using Bayesian Adaptive Randomization. Journal of Clinical Oncology, 41(36), 5524–5535. https://doi.org/10.1200/jco.23.00493

Goodwin, P. J., Chen, B. E., Gelmon, K. A., Whelan, T. J., Ennis, M., Lemieux, J., Ligibel, J. A., Hershman, D. L., Mayer, I. A., Hobday, T. J., Bliss, J. M., Rastogi, P., Rabaglio-Poretti, M., Thompson, A. M., Rea, D. W., Stos, P. M., Shepherd, L. E., Stambolic, V., & Parulekar, W. R. (2023). Effect of Metformin Versus Placebo on New Primary Cancers in Canadian Cancer Trials Group MA.32: A Secondary Analysis of a Phase III Randomized Double-Blind Trial in Early Breast Cancer. Journal of Clinical Oncology, 41(35), 5356–5362. https://doi.org/10.1200/jco.23.00296

Oxnard, G. R., Chen, R., Pharr, J. C., Koeller, D. R., Bertram, A. A., Dahlberg, S. E., Rainville, I., Shane-Carson, K., Taylor, K. A., Sable-Hunt, A., Sholl, L. M., Teerlink, C. C., Thomas, A., Cannon-Albright, L. A., Fay, A. P., Ashton-Prolla, P., Yang, H., Salvatore, M. M., Addario, B. J., … Garber, J. E. (2023). Germline EGFR Mutations and Familial Lung Cancer. Journal of Clinical Oncology, 41(34), 5274–5284. https://doi.org/10.1200/jco.23.01372

Sanft, T., Harrigan, M., McGowan, C., Cartmel, B., Zupa, M., Li, F.-Y., Ferrucci, L. M., Puklin, L., Cao, A., Nguyen, T. H., Neuhouser, M. L., Hershman, D. L., Basen-Engquist, K., Jones, B. A., Knobf, T., Chagpar, A. B., Silber, A., Tanasijevic, A., Ligibel, J. A., & Irwin, M. L. (2023). Randomized Trial of Exercise and Nutrition on Chemotherapy Completion and Pathologic Complete Response in Women With Breast Cancer: The Lifestyle, Exercise, and Nutrition Early After Diagnosis Study. Journal of Clinical Oncology, 41(34), 5285–5295. https://doi.org/10.1200/jco.23.00871

Kilbride, M., Egleston, B. L., Chung, W. K., Olopade, O., Maxwell, K. N., Shah, P., Churpek, J. E., Fleisher, L., Terry, M. B., Fetzer, D., Gaieski, J. B., Bulafka, J., Espinal, A., Karpink, K., Walser, S., Singleton, D., Palese, M., Siljander, I., Brandt, A., … Bradbury, A. R. (2023). Uptake of Genetic Research Results and Patient-Reported Outcomes With Return of Results Incorporating Web-Based Predisclosure Education. Journal of Clinical Oncology, 41(31), 4905–4915. https://doi.org/10.1200/jco.22.00516

Jenssen, B. P., Schnoll, R., Beidas, R. S., Bekelman, J., Bauer, A.-M., Evers-Casey, S., Fisher, T., Scott, C., Nicoloso, J., Gabriel, P., Asch, D. A., Buttenheim, A. M., Chen, J., Melo, J., Grant, D., Horst, M., Oyer, R., Shulman, L. N., Clifton, A. B. W., … Leone, F. T. (2023). Cluster Randomized Pragmatic Clinical Trial Testing Behavioral Economic Implementation Strategies to Improve Tobacco Treatment for Patients With Cancer Who Smoke. Journal of Clinical Oncology, 41(28), 4511–4521. https://doi.org/10.1200/jco.23.00355

Wen, P. Y., van den Bent, M., Youssef, G., Cloughesy, T. F., Ellingson, B. M., Weller, M., Galanis, E., Barboriak, D. P., de Groot, J., Gilbert, M. R., Huang, R., Lassman, A. B., Mehta, M., Molinaro, A. M., Preusser, M., Rahman, R., Shankar, L. K., Stupp, R., Villanueva-Meyer, J. E., … Chang, S. M. (2023). RANO 2.0: Update to the Response Assessment in Neuro-Oncology Criteria for High- and Low-Grade Gliomas in Adults. Journal of Clinical Oncology, 41(33), 5187–5199. https://doi.org/10.1200/jco.23.01059

Pratz, K. W., Cherry, M., Altman, J. K., Cooper, B. W., Podoltsev, N. A., Cruz, J. C., Lin, T. L., Schiller, G. J., Jurcic, J. G., Asch, A., Wu, R., Hill, J. E., Gill, S. C., James, A. J., Rich, E. S., Hasabou, N., Perl, A. E., & Levis, M. J. (2023). Gilteritinib in Combination With Induction and Consolidation Chemotherapy and as Maintenance Therapy: A Phase IB Study in Patients With Newly Diagnosed AML. Journal of Clinical Oncology, 41(26), 4236–4246. https://doi.org/10.1200/jco.22.02721

Ingham, M., Allred, J. B., Chen, L., Das, B., Kochupurakkal, B., Gano, K., George, S., Attia, S., Burgess, M. A., Seetharam, M., Boikos, S. A., Bui, N., Chen, J. L., Close, J. L., Cote, G. M., Thaker, P. H., Ivy, S. P., Bose, S., D’Andrea, A., … Schwartz, G. K. (2023). Phase II Study of Olaparib and Temozolomide for Advanced Uterine Leiomyosarcoma (NCI Protocol 10250). Journal of Clinical Oncology, 41(25), 4154–4163. https://doi.org/10.1200/jco.23.00402

Kalinsky, K., Accordino, M. K., Chiuzan, C., Mundi, P. S., Sakach, E., Sathe, C., Ahn, H., Trivedi, M. S., Novik, Y., Tiersten, A., Raptis, G., Baer, L. N., Oh, S. Y., Zelnak, A. B., Wisinski, K. B., Andreopoulou, E., Gradishar, W. J., Stringer-Reasor, E., Reid, S. A., … Hershman, D. L. (2023). Randomized Phase II Trial of Endocrine Therapy With or Without Ribociclib After Progression on Cyclin-Dependent Kinase 4/6 Inhibition in Hormone Receptor–Positive, Human Epidermal Growth Factor Receptor 2–Negative Metastatic Breast Cancer: MAINTAIN Trial. Journal of Clinical Oncology, 41(24), 4004–4013. https://doi.org/10.1200/jco.22.02392

Morris, M. J., Heller, G., Hillman, D. W., Bobek, O., Ryan, C., Antonarakis, E. S., Bryce, A. H., Hahn, O., Beltran, H., Armstrong, A. J., Schwartz, L., Lewis, L. D., Beumer, J. H., Langevin, B., McGary, E. C., Mehan, P. T., Goldkorn, A., Roth, B. J., Xiao, H., … Small, E. J. (2023). Randomized Phase III Study of Enzalutamide Compared With Enzalutamide Plus Abiraterone for Metastatic Castration-Resistant Prostate Cancer (Alliance A031201 Trial). Journal of Clinical Oncology, 41(18), 3352–3362. https://doi.org/10.1200/jco.22.02394

Baker, S. D., Bates, S. E., Brooks, G. A., Dahut, W. L., Diasio, R. B., El-Deiry, W. S., Evans, W. E., Figg, W. D., Hertz, D. L., Hicks, J. K., Kamath, S., Kasi, P. M., Knepper, T. C., McLeod, H. L., O’Donnell, P. H., Relling, M. V., Rudek, M. A., Sissung, T. M., Smith, D. M., … Walko, C. M. (2023). DPYD Testing: Time to Put Patient Safety First. Journal of Clinical Oncology, 41(15), 2701–2705. https://doi.org/10.1200/jco.22.02364

Sallman, D. A., Al Malki, M. M., Asch, A. S., Wang, E. S., Jurcic, J. G., Bradley, T. J., Flinn, I. W., Pollyea, D. A., Kambhampati, S., Tanaka, T. N., Zeidner, J. F., Garcia-Manero, G., Jeyakumar, D., Komrokji, R., Lancet, J., Kantarjian, H. M., Gu, L., Zhang, Y., Tan, A., … Daver, N. G. (2023). Magrolimab in Combination With Azacitidine in Patients With Higher-Risk Myelodysplastic Syndromes: Final Results of a Phase Ib Study. Journal of Clinical Oncology, 41(15), 2815–2826. https://doi.org/10.1200/jco.22.01794

Wang, M. L., Jurczak, W., Zinzani, P. L., Eyre, T. A., Cheah, C. Y., Ujjani, C. S., Koh, Y., Izutsu, K., Gerson, J. N., Flinn, I., Tessoulin, B., Alencar, A. J., Ma, S., Lewis, D., Lech-Maranda, E., Rhodes, J., Patel, K., Maddocks, K., Lamanna, N., … Shah, N. N. (2023). Pirtobrutinib in Covalent Bruton Tyrosine Kinase Inhibitor Pretreated Mantle-Cell Lymphoma. Journal of Clinical Oncology, 41(24), 3988–3997. https://doi.org/10.1200/jco.23.00562

Bernstein, E., Lev-Ari, S., Shapira, S., Leshno, A., Sommer, U., Al-Shamsi, H., Shaked, M., Segal, O., Galazan, L., Hay-Levy, M., Sror, M., Harlap-Gat, A., Peer, M., Moshkowitz, M., Wolf, I., Liberman, E., Shenberg, G., Gur, E., Elran, H., … Arber, N. (2023). Data From a One-Stop-Shop Comprehensive Cancer Screening Center. Journal of Clinical Oncology, 41(14), 2503–2510. https://doi.org/10.1200/jco.22.00938

Geller, A. C., Coroiu, A., Keske, R. R., Haneuse, S., Davine, J. A., Emmons, K. M., Daniel, C. L., Gibson, T. M., McDonald, A. J., Robison, L. L., Mertens, A. C., Elkin, E. B., Marghoob, A., & Armstrong, G. T. (2023). Advancing Survivors Knowledge (ASK Study) of Skin Cancer Surveillance After Childhood Cancer: A Randomized Controlled Trial in the Childhood Cancer Survivor Study. Journal of Clinical Oncology, 41(12), 2269–2280. https://doi.org/10.1200/jco.22.00408

Gounder, M. M., Bauer, T. M., Schwartz, G. K., Weise, A. M., LoRusso, P., Kumar, P., Tao, B., Hong, Y., Patel, P., Lu, Y., Lesegretain, A., Tirunagaru, V. G., Xu, F., Doebele, R. C., & Hong, D. S. (2023). A First-in-Human Phase I Study of Milademetan, an MDM2 Inhibitor, in Patients With Advanced Liposarcoma, Solid Tumors, or Lymphomas. Journal of Clinical Oncology, 41(9), 1714–1724. https://doi.org/10.1200/jco.22.01285

Lehrnbecher, T., Robinson, P. D., Ammann, R. A., Fisher, B., Patel, P., Phillips, R., Beauchemin, M. P., Carlesse, F., Castagnola, E., Davis, B. L., Elgarten, C. W., Groll, A. H., Haeusler, G. M., Koenig, C., Santolaya, M. E., Tissing, W. J. E., Wolf, J., Alexander, S., Hu, H., … Sung, L. (2023). Guideline for the Management of Fever and Neutropenia in Pediatric Patients With Cancer and Hematopoietic Cell Transplantation Recipients: 2023 Update. Journal of Clinical Oncology, 41(9), 1774–1785. https://doi.org/10.1200/jco.22.02224

Fu, S., Yao, S., Yuan, Y., Previs, R. A., Elias, A. D., Carvajal, R. D., George, T. J., Yuan, Y., Yu, L., Westin, S. N., Xing, Y., Dumbrava, E. E., Karp, D. D., Piha-Paul, S. A., Tsimberidou, A. M., Ahnert, J. R., Takebe, N., Lu, K., Keyomarsi, K., & Meric-Bernstam, F. (2023). Multicenter Phase II Trial of the WEE1 Inhibitor Adavosertib in Refractory Solid Tumors Harboring CCNE1 Amplification. Journal of Clinical Oncology, 41(9), 1725–1734. https://doi.org/10.1200/jco.22.00830

Muchtar, E., Dispenzieri, A., Wisniowski, B., Palladini, G., Milani, P., Merlini, G., Schönland, S., Veelken, K., Hegenbart, U., Geyer, S. M., Kumar, S. K., Kastritis, E., Dimopoulos, M. A., Liedtke, M., Witteles, R., Sanchorawala, V., Szalat, R., Landau, H., Petrlik, E., … Gertz, M. A. (2023). Graded Cardiac Response Criteria for Patients With Systemic Light Chain Amyloidosis. Journal of Clinical Oncology, 41(7), 1393–1403. https://doi.org/10.1200/jco.22.00643

Dbouk, M., Katona, B. W., Brand, R. E., Chak, A., Syngal, S., Farrell, J. J., Kastrinos, F., Stoffel, E. M., Canto, M. I., & Goggins, M. (2023). Reply to S. Raoof. Journal of Clinical Oncology, 41(5), 1147–1149. https://doi.org/10.1200/jco.22.01915

Paice, J. A., Bohlke, K., Barton, D., Craig, D. S., El-Jawahri, A., Hershman, D. L., Kong, L. R., Kurita, G. P., LeBlanc, T. W., Mercadante, S., Novick, K. L. M., Sedhom, R., Seigel, C., Stimmel, J., & Bruera, E. (2023). Use of Opioids for Adults With Pain From Cancer or Cancer Treatment: ASCO Guideline. Journal of Clinical Oncology, 41(4), 914–930. https://doi.org/10.1200/jco.22.02198

Brastianos, P. K., Twohy, E. L., Gerstner, E. R., Kaufmann, T. J., Iafrate, A. J., Lennerz, J., Jeyapalan, S., Piccioni, D. E., Monga, V., Fadul, C. E., Schiff, D., Taylor, J. W., Chowdhary, S. A., Bettegowda, C., Ansstas, G., De La Fuente, M., Anderson, M. D., Shonka, N., Damek, D., … Galanis, E. (2023). Alliance A071401: Phase II Trial of Focal Adhesion Kinase Inhibition in Meningiomas With Somatic NF2 Mutations. Journal of Clinical Oncology, 41(3), 618–628. https://doi.org/10.1200/jco.21.02371

Schultz, L. M., Eaton, A., Baggott, C., Rossoff, J., Prabhu, S., Keating, A. K., Krupski, C., Pacenta, H., Philips, C. L., Talano, J.-A., Moskop, A., Baumeister, S. H. C., Myers, G. D., Karras, N. A., Brown, P. A., Qayed, M., Hermiston, M., Satwani, P., Wilcox, R., … Stefanski, H. (2023). Outcomes After Nonresponse and Relapse Post-Tisagenlecleucel in Children, Adolescents, and Young Adults With B-Cell Acute Lymphoblastic Leukemia. Journal of Clinical Oncology, 41(2), 354–363. https://doi.org/10.1200/jco.22.01076

Dbouk, M., Katona, B. W., Brand, R. E., Chak, A., Syngal, S., Farrell, J. J., Kastrinos, F., Stoffel, E. M., Blackford, A. L., Rustgi, A. K., Dudley, B., Lee, L. S., Chhoda, A., Kwon, R., Ginsberg, G. G., Klein, A. P., Kamel, I., Hruban, R. H., He, J., … Goggins, M. (2022). The Multicenter Cancer of Pancreas Screening Study: Impact on Stage and Survival. Journal of Clinical Oncology, 40(28), 3257–3266. https://doi.org/10.1200/jco.22.00298

Yeung, A. R., Deshmukh, S., Klopp, A. H., Gil, K. M., Wenzel, L., Westin, S. N., Konski, A. A., Gaffney, D. K., Small, W., Thompson, J. S., Doncals, D. E., Cantuaria, G. H. C., D’Souza, D. P., Chang, A., Kundapur, V., Mohan, D. S., Haas, M. L., Kim, Y. B., Ferguson, C. L., … Bruner, D. W. (2022). Intensity-Modulated Radiation Therapy Reduces Patient-Reported Chronic Toxicity Compared With Conventional Pelvic Radiation Therapy: Updated Results of a Phase III Trial. Journal of Clinical Oncology, 40(27), 3115–3119. https://doi.org/10.1200/jco.21.02831

Pemmaraju, N., Sweet, K. L., Stein, A. S., Wang, E. S., Rizzieri, D. A., Vasu, S., Rosenblat, T. L., Brooks, C. L., Habboubi, N., Mughal, T. I., Kantarjian, H., Konopleva, M., & Lane, A. A. (2022). Long-Term Benefits of Tagraxofusp for Patients With Blastic Plasmacytoid Dendritic Cell Neoplasm. Journal of Clinical Oncology, 40(26), 3032–3036. https://doi.org/10.1200/jco.22.00034

Lassman, A. B., Hoang-Xuan, K., Polley, M.-Y. C., Brandes, A. A., Cairncross, J. G., Kros, J. M., Ashby, L. S., Taphoorn, M. J. B., Souhami, L., Dinjens, W. N. M., Laack, N. N., Kouwenhoven, M. C. M., Fink, K. L., French, P. J., Macdonald, D. R., Lacombe, D., Won, M., Gorlia, T., Mehta, M. P., & van den Bent, M. J. (2022). Joint Final Report of EORTC 26951 and RTOG 9402: Phase III Trials With Procarbazine, Lomustine, and Vincristine Chemotherapy for Anaplastic Oligodendroglial Tumors. Journal of Clinical Oncology, 40(23), 2539–2545. https://doi.org/10.1200/jco.21.02543

Gounder, M. M., Razak, A. A., Somaiah, N., Chawla, S., Martin-Broto, J., Grignani, G., Schuetze, S. M., Vincenzi, B., Wagner, A. J., Chmielowski, B., Jones, R. L., Riedel, R. F., Stacchiotti, S., Loggers, E. T., Ganjoo, K. N., Le Cesne, A., Italiano, A., Garcia del Muro, X., Burgess, M., … Attia, S. (2022). Selinexor in Advanced, Metastatic Dedifferentiated Liposarcoma: A Multinational, Randomized, Double-Blind, Placebo-Controlled Trial. Journal of Clinical Oncology, 40(22), 2479–2490. https://doi.org/10.1200/jco.21.01829

Qin, B., Kim, K., Goldman, N., Rundle, A. G., Chanumolu, D., Zeinomar, N., Xu, B., Pawlish, K. S., Ambrosone, C. B., Demissie, K., Hong, C.-C., Lovasi, G. S., & Bandera, E. V. (2022). Multilevel Factors for Adiposity Change in a Population-Based Prospective Study of Black Breast Cancer Survivors. Journal of Clinical Oncology, 40(20), 2213–2223. https://doi.org/10.1200/jco.21.02973

Carvajal, R. D., Nathan, P., Sacco, J. J., Orloff, M., Hernandez-Aya, L. F., Yang, J., Luke, J. J., Butler, M. O., Stanhope, S., Collins, L., McAlpine, C., Holland, C., Abdullah, S. E., & Sato, T. (2022). Phase I Study of Safety, Tolerability, and Efficacy of Tebentafusp Using a Step-Up Dosing Regimen and Expansion in Patients With Metastatic Uveal Melanoma. Journal of Clinical Oncology, 40(17), 1939–1948. https://doi.org/10.1200/jco.21.01805